Jim Simons Oncolytics Biotech Inc Transaction History

Renaissance Technologies LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.2 - $1.91 $20,707 - $32,958	17,256 Added 15.33%	129,856 $156,000
Q4 2022 Feb 13, 2023	BUY	$1.17 - $2.12 $102,960 - $186,560	88,000 Added 357.72%	112,600 $184,000
Q3 2022 Nov 14, 2022	BUY	$0.98 - $1.51 $10,388 - $16,006	10,600 Added 75.71%	24,600 $30,000
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.59 $9,775 - $18,285	-11,500 Reduced 45.1%	14,000 $14,000
Q1 2022 May 13, 2022	SELL	$1.31 - $2.02 $275,071 - $424,155	-209,978 Reduced 89.17%	25,500 $40,000
Q4 2021 Feb 11, 2022	BUY	$1.39 - $2.3 $35,553 - $58,829	25,578 Added 12.19%	235,478 $327,000
Q3 2021 Nov 12, 2021	BUY	$1.93 - $2.77 $360,717 - $517,713	186,900 Added 812.61%	209,900 $439,000
Q2 2021 Aug 13, 2021	BUY	$2.6 - $4.64 $59,800 - $106,719	23,000 New	23,000 $64,000
Q1 2021 May 13, 2021	SELL	$2.32 - $4.11 $404,190 - $716,044	-174,220 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.71 - $4.03 $276,395 - $651,389	161,635 Added 1284.35%	174,220 $415,000
Q3 2020 Nov 13, 2020	BUY	$1.58 - $2.15 $19,884 - $27,057	12,585 New	12,585 $21,000
Q2 2020 Aug 13, 2020	SELL	$1.33 - $2.76 $55,858 - $115,917	-41,999 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$0.98 - $4.28 $41,159 - $179,755	41,999 New	41,999 $58,000
Q4 2019 Feb 13, 2020	SELL	$0.42 - $4.76 $15,855 - $179,694	-37,751 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$0.54 - $1.71 $20,385 - $64,554	37,751 New	37,751 $22,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $53.8M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.